Physician profile
Meredith A Spindler
NPI 1003074584
$23,435.50
in general payments reported to CMS, 2019-2025
11 companies · $1,592 in 2025
The $1,592 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,450 · 2021: $2,600 · 2022: $6,014 · 2023: $6,418 · 2024: $3,362 · 2025: $1,592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,150 · Food and Beverage: $2,122 · Travel and Lodging: $2,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,150.00 |
| Food and Beverage | $2,121.67 |
| Travel and Lodging | $2,099.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12,656.66 | 2019-2025 | Vercise, General - Dbs |
| Medtronic, INC. | $6,061.97 | 2021-2024 | Percept PC Brainsense |
| Mdd US Operations, LLC | $3,898.12 | 2022 | |
| Supernus Pharmaceuticals, INC. | $290.07 | 2024 | Qelbree |
| Neurocrine Biosciences, INC. | $240.72 | 2022-2023 | |
| Insightec,INC | $145.84 | 2025 | Exablate |
| Abbott Laboratories | $142.12 | 2025 | Infinity |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Spindler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.